Curcumin (Not yet branded)
Other Medications
Description
Curcumin is a natural polyphenolic compound derived from turmeric (Curcuma longa) that has shown potential chemopreventive properties in colorectal cancer. In CRC applications, curcumin is primarily evaluated for its ability to reduce precancerous lesions such as aberrant crypt foci and adenomatous polyps. The compound has been studied specifically in patients with familial adenomatous polyposis (FAP), a hereditary condition that predisposes individuals to colorectal cancer development.
Mechanism of Action
Curcumin exerts its effects through multiple molecular pathways, including inhibition of nuclear factor-kappa B (NF- B), cyclooxygenase-2 (COX-2), and various inflammatory cytokines. The compound also modulates cell cycle progression, promotes apoptosis in abnormal cells, and exhibits antioxidant properties that may help prevent DNA damage in colonic epithelium.
Molecular Targets
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Brand Name | Not yet branded |
| Category | Other Medications |
 Status | Off-label |
 EMA Status | Not submitted to EMA |
 Spain Access | Not available |
| Administration | Oral |
| Clinical Trials | 2 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.